rituximab
roche,biogen
[]
puechal et al rtx vs cyc induction in gpa: target trial emulation study. bvas 0 and pred=&lt;10mg at 6 months 73% rtx vs 40% cyc. rr 1.82[95%ci:1.22;2.73] #acr22 abstr#1084 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC